Hims & Hers Health (NYSE:HIMS – Get Free Report) is projected to announce its earnings results after the market closes on ...

The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk’s popular weight-loss and ...

State of New Jersey Common Pension Fund D decreased its position in shares of Hims & Hers Health, Inc. (NYSE:HIMS – Free ...

Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply, the FDA declared ...

The U.S. stock market had one of its worst weeks so far in 2025, weighed down by inflation concerns and weaker-than-expected ...

One Oakwood sixth grader is using her own experience with loss to help other kids going through the same thing.

Rachel Maddow breaks down new reporting that the Trump administration is slashing the budget of an Alzheimer’s research ...